HedgeChatter

  • Home /
  • Tag Archives

pdl

Biotech Stocks Technical Study — Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma

LONDON, March 18, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI), Amarin Corporation PLC (NASDAQ: AMRN), and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP). Free research report on Orexigen Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Orexigen%20Therapeutics&d=18-Mar-2015&s=OREX. […]

March 18, 2015 , , , , , , , , , , , Comments Off on Biotech Stocks Technical Study — Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma read more

3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc.

Source: StockMonkeys.com via Flickr.It’s been a truly transformative year for Gilead Sciences and its shareholders. Even taking into consideration the latest swoon in Gilead’s share price tied to the approval of AbbVie ‘s Viekira Pak and its subsequent multi-year agreement with Express Scripts , Gilead shares are up 25% for the year, essentially doubling the return of the S&P 500 […]

January 3, 2015 , , , , , , , , , , Comments Off on 3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc. read more